---
figid: PMC6509750__fped-07-00176-g0003
figtitle: Influence of TGFB1 on the balance between the canonical WNT/Beta-catenin
  signaling and PPARG
organisms:
- NA
pmcid: PMC6509750
filename: fped-07-00176-g0003.jpg
figlink: /pmc/articles/PMC6509750/figure/F3/
number: F3
caption: Influence of TGF-β1 on the balance between the canonical WNT/β-catenin signaling
  and PPARγ. In the presence of the WNT ligands, the WNT receptor binds both LRP5/6
  and FZD receptors to initiate LRP phosphorylation and DSH-mediated Frizzled internalization.
  This leads to the dissociation of the GSK-3 β/AXIN/APC destruction complex. Phosphorylation
  of β-catenin is inhibited and β-catenin accumulates in the cytosol and then translocates
  to the nucleus to bind TCF-LEF transcription factors. This leads to the WNT-response
  gene transcription (PDK, MCT-1, cMyc, and Cyclin D1). PPARγ inhibits the β-catenin/TCF-LEF-induced
  activation of WNT target genes. TGF-β also enhances WNT signaling through the inhibition
  of DKK1. DKK1 is activated by PPARγ. TGF-β1 binds type 2 TGF-βR2 receptor (TGF-βR2),
  which recruits type 1 TGF-βR1 receptor (TGF-βR1). This results in the formation
  of a heterotetramer that phosphorylates Smad. The Smad complex then translocates
  to the nucleus and regulates the transcription of target genes (CTGF, COL1A). A
  non-Smad pathway also occurs through PI3K-AKT. PTEN inhibits PI3K-AKT and PPARγ
  inhibits AKT. APC, adenomatous polyposis coli; CTGF, Connective tissue growth factor;
  DKK1, Dickkopf-1; DSH, Disheveled; FZD, Frizzled; GSK-3β, glycogen synthase kinase-3β;
  LRP5/6, low-density lipoprotein receptor-related protein 5/6; MCT-1, monocarboxylate
  lactate transporter-1; PPARγ, peroxisome proliferator-activated receptor gamma;
  PI3K, phosphatidylinositol 3-kinase and AKT, AKT/Protein Kinase B; PTEN, Phosphatase
  and tensin homolog; PDK, pyruvate; dehydrogenase kinase; TCF/LEF, T-cell factor/lymphoid
  enhancer factor; TGF, Transforming Growth Factor.
papertitle: 'Bronchopulmonary Dysplasia: Crosstalk Between PPARγ, WNT/β-Catenin and
  TGF-β Pathways; The Potential Therapeutic Role of PPARγ Agonists.'
reftext: Yves Lecarpentier, et al. Front Pediatr. 2019;7:176.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9570535
figid_alias: PMC6509750__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6509750__F3
ndex: 7860c5cb-dee0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6509750__fped-07-00176-g0003.html
  '@type': Dataset
  description: Influence of TGF-β1 on the balance between the canonical WNT/β-catenin
    signaling and PPARγ. In the presence of the WNT ligands, the WNT receptor binds
    both LRP5/6 and FZD receptors to initiate LRP phosphorylation and DSH-mediated
    Frizzled internalization. This leads to the dissociation of the GSK-3 β/AXIN/APC
    destruction complex. Phosphorylation of β-catenin is inhibited and β-catenin accumulates
    in the cytosol and then translocates to the nucleus to bind TCF-LEF transcription
    factors. This leads to the WNT-response gene transcription (PDK, MCT-1, cMyc,
    and Cyclin D1). PPARγ inhibits the β-catenin/TCF-LEF-induced activation of WNT
    target genes. TGF-β also enhances WNT signaling through the inhibition of DKK1.
    DKK1 is activated by PPARγ. TGF-β1 binds type 2 TGF-βR2 receptor (TGF-βR2), which
    recruits type 1 TGF-βR1 receptor (TGF-βR1). This results in the formation of a
    heterotetramer that phosphorylates Smad. The Smad complex then translocates to
    the nucleus and regulates the transcription of target genes (CTGF, COL1A). A non-Smad
    pathway also occurs through PI3K-AKT. PTEN inhibits PI3K-AKT and PPARγ inhibits
    AKT. APC, adenomatous polyposis coli; CTGF, Connective tissue growth factor; DKK1,
    Dickkopf-1; DSH, Disheveled; FZD, Frizzled; GSK-3β, glycogen synthase kinase-3β;
    LRP5/6, low-density lipoprotein receptor-related protein 5/6; MCT-1, monocarboxylate
    lactate transporter-1; PPARγ, peroxisome proliferator-activated receptor gamma;
    PI3K, phosphatidylinositol 3-kinase and AKT, AKT/Protein Kinase B; PTEN, Phosphatase
    and tensin homolog; PDK, pyruvate; dehydrogenase kinase; TCF/LEF, T-cell factor/lymphoid
    enhancer factor; TGF, Transforming Growth Factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - DKK1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CXCL11
  - LRP6
  - LRP5
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - ADAR
  - DVL1P1
  - AXIN1
  - AXIN2
  - PTEN
  - APC
  - PROC
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CTNNB1
  - HNF4A
  - MYC
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - MCTS1
  - CCN2
  - Cancer
---
